Akero Therapeutics (NASDAQ:AKRO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Akero Therapeutics (AKRO) operate in?

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Akero Therapeutics Stock (NASDAQ: AKRO) stock price, news, charts, stock research, profile.

Open	$26.72
Close	-
Volume / Avg.	49.67K / 652.60K
Day Range	$26.46 - $26.97
52 Wk Range	11.25 - 53.77
Market Cap	$1.84B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	10.55%
Days to Cover	15.06

Recent News

Oxford Industries Reports Weak Results, Joins Viper Energy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a loss of 56 cents per share in the year-ago quarter.

Zacks

This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's Q2 FY24 earnings report on August 8 will include a pre-tax IPR&D charge of $154 million, impacting GAAP and non-GAAP EPS by $0.14.

Shivani Kumaresan

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jun

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Akero Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercia...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Akero Therapeutics (AKRO) stock?

You can purchase shares of Akero Therapeutics (NASDAQ:AKRO) through any online brokerage.

View our list of the best stock brokerages

Who are Akero Therapeutics (AKRO) competitors?

Other companies in Akero Therapeutics’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX), CareDx (NASDAQ:CDNA), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Bicycle Therapeutics (NASDAQ:BCYC).

What is the forecast, or price target, for Akero Therapeutics (AKRO) stock?

Akero Therapeutics has a consensus price target of $41.25.

What is the current price for Akero Therapeutics (AKRO)?

The stock price for Akero Therapeutics (NASDAQ: AKRO) is $26.57 last updated September 18, 2024 at 10:21 AM EDT.

Does Akero Therapeutics (AKRO) pay a dividend?

There are no upcoming dividends for Akero Therapeutics.

When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?

Akero Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.

Is Akero Therapeutics (AKRO) going to split?

There is no upcoming split for Akero Therapeutics.

What sector and industry does Akero Therapeutics (AKRO) operate in?

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now